Asia Pacific Prenatal & Newborn Genetic Testing Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Product (Diagnostic, and Screening), Disease Indication (Cystic Fibrosis, Sickle Cell Anemia, Down Syndrome, Phenylketonuria, Recurrent Pregnancy Loss, Antiphospholipid Syndrome (APL), and Other Diseases), Technology (Spectrophotometer, Polymerase Chain Reaction, Fluorescence In-situ Hybridization, Array Comparative Genomic Hybridization, and Others), End User (Hospitals & Clinics, Diagnostic Centers, and Other End User) and Geography

No. of Pages: 281    |    Report Code: TIPRE00006470    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Prenatal & Newborn Genetic Testing Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Prenatal & Newborn Genetic Testing Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Prenatal & Newborn Genetic Testing Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 High Prevalence of Genetic Diseases in Infants
5.2 Market Opportunities
  • 5.2.1 Digital Microfluidics Poses a New Trend for the Newborn Screening
5.3 Future Trends
  • 5.3.1 Government Support to Encourage Prenatal and Newborn Testing
5.4 Impact of Drivers and Restraints

6. Asia Pacific Prenatal & Newborn Genetic Testing Market Regional Analysis

6.1 Asia Pacific Prenatal & Newborn Genetic Testing Market Overview
6.2 Asia Pacific Prenatal & Newborn Genetic Testing Market Revenue 2016-2027 (US$ Million)
6.3 Asia Pacific Prenatal & Newborn Genetic Testing Market Forecast Analysis

7. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Product

7.1 Diagnostic
  • 7.1.1 Overview
  • 7.1.2 Diagnostic: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Screening
  • 7.2.1 Overview
  • 7.2.2 Screening: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Disease Indication

8.1 Cystic Fibrosis
  • 8.1.1 Overview
  • 8.1.2 Cystic Fibrosis: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Sickle Cell Anemia
  • 8.2.1 Overview
  • 8.2.2 Sickle Cell Anemia: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Down Syndrome
  • 8.3.1 Overview
  • 8.3.2 Down Syndrome: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Phenylketonuria
  • 8.4.1 Overview
  • 8.4.2 Phenylketonuria: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Recurrent Pregnancy Loss
  • 8.5.1 Overview
  • 8.5.2 Recurrent Pregnancy Loss: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Antiphospholipid Syndrome
  • 8.6.1 Overview
  • 8.6.2 Antiphospholipid Syndrome: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Other Diseases
  • 8.7.1 Overview
  • 8.7.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis – by Technology

9.1 Spectrophotometer
  • 9.1.1 Overview
  • 9.1.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Polymerase Chain Reaction
  • 9.2.1 Overview
  • 9.2.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Fluorescence In-situ Hybridization
  • 9.3.1 Overview
  • 9.3.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Array Comparative Genomic Hybridization
  • 9.4.1 Overview
  • 9.4.2 Other Diseases: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia Pacific Prenatal & Newborn Genetic Testing Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Key Country, 2019 and 2027 (%)
  • 10.1.1.1 Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 10.1.1.1.2 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 10.1.1.1.3 China: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
  • 10.1.1.2 India: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 10.1.1.2.2 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 10.1.1.2.3 India: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
  • 10.1.1.3 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 10.1.1.3.2 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 10.1.1.3.3 Japan: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
  • 10.1.1.4 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 10.1.1.4.2 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 10.1.1.4.3 Australia: Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Product
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Disease Indication
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Prenatal & Newborn Genetic Testing Market Breakdown, by Technology

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Prenatal & Newborn Genetic Testing Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 LifeCell
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Quest Diagnostics Incorporated
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Medgenome
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Eurofins Scientific
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Metropolis India
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 SRL Diagnostics
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Sandor Lifesciences Pvt Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 PerkinElmer, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Natera, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Laboratory Corporation of America Holdings (Sequenom)
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Genes2Me LLP
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Illumina, Inc.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia Pacific Prenatal & Newborn Genetic Testing Market

The List of Companies - Asia Pacific Prenatal and Newborn Genetic Testing Market

  1. LifeCell
  2. Quest Diagnostics Incorporated
  3. Medgenome
  4. Eurofins Scientific
  5. Metropolis India
  6. SRL Diagnostics
  7. Sandor Lifesciences Pvt Ltd
  8. PerkinElmer, Inc.
  9. Natera, Inc.
  10. Laboratory Corporation of America Holdings (Sequenom)
  11. Genes2Me LLP
  12. Illumina, Inc.

 

asia-pacific-prenatal-and-newborn-genetic-testing-market